Product Information
SILDENAFIL 20 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0510 per EA under NDC 68001059705. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Dec 17, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001059705
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203814FDA Approved
12/17/2013
TE Code
AB
On Market Since
6/12/2023
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 20 MG TABLET has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0510 per EA |
|---|---|
| All-time high | $0.0967 (Feb 14, 2024) |
| All-time low | $0.0441 (Nov 20, 2024) |
| 52-week high | $0.0730 |
| 52-week low | $0.0510 |
| Median price | $0.0638 |
| Average price | $0.0661 |
| Largest weekly change | -46.9% (Nov 20, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sildenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 20 MG TABLET, manufactured by BluePoint Laboratories, is $0.0510 per EA (NDC 68001059705), effective Sep 30, 2026.
How has the price of SILDENAFIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 20 MG TABLET has declined 26.1%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 20 MG TABLET?
Since Nov 8, 2023, the NADAC for SILDENAFIL 20 MG TABLET has ranged from a low of $0.0441 (Nov 20, 2024) to a high of $0.0967 (Feb 14, 2024), with a median of $0.0638 per EA.
Are there cheaper alternatives to SILDENAFIL 20 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SILDENAFIL 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SILDENAFIL 20 MG TABLET?
SILDENAFIL 20 MG TABLET (NDC 68001059705) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.